ICF external fairs target group drug development EU (Q3071769): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
ICF Salons externes du groupe cible développement des drogues UE | |||
Revision as of 06:58, 26 November 2021
Project Q3071769 in Estonia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ICF external fairs target group drug development EU |
Project Q3071769 in Estonia |
Statements
41,952.98 Euro
0 references
52,441.23 Euro
0 references
80.0 percent
0 references
1 May 2019
0 references
30 November 2020
0 references
Icosagen Cell Factory OÜ
0 references
58°22'0.84"N, 26°39'47.41"E
0 references
61713
0 references
Icosagen Cell Factory OÜ kommertsialiseerib patenteeritud tehnoloogiaid läbi antikehade arendamise ja tootmise teenuse osutamise diagnostika- ja farmaatsiaettevõtetele. Valitud ärimudeli puhul mõjutab müügitulemusi tehnoloogilisele võimekusele lisaks ka isiklik suhtlus klientidega. Euroopa ravimiarenduse turul suhtevõrgustiku arendamise ja seeläbi teenuse eksportmüügi edendamise peamiseks vahendiks on ettevõtte esitlemine suurimatel Euroopa ravimiarenduse messidel ja konverentsidel. (Estonian)
0 references
Icosagen Cell Factory OÜ commercialises patented technologies through the development and production of antibodies to diagnostic and pharmaceutical companies. In the chosen business model, personal communication with customers not only influences the technological performance of the sales results. The main means of developing a network of relationships in the European pharmaceutical development market and thus promoting export sales of the service are the presentation of the company at the largest European pharmaceutical development fairs and conferences. (English)
16 August 2021
0 references
Identifiers
2014-2020.5.01.19-1116
0 references